1. Home
  2. PASW vs COCP Comparison

PASW vs COCP Comparison

Compare PASW & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASW
  • COCP
  • Stock Information
  • Founded
  • PASW 2021
  • COCP 2006
  • Country
  • PASW Hong Kong
  • COCP United States
  • Employees
  • PASW N/A
  • COCP N/A
  • Industry
  • PASW Apparel
  • COCP Biotechnology: Pharmaceutical Preparations
  • Sector
  • PASW Consumer Discretionary
  • COCP Health Care
  • Exchange
  • PASW Nasdaq
  • COCP Nasdaq
  • Market Cap
  • PASW 15.9M
  • COCP 15.4M
  • IPO Year
  • PASW N/A
  • COCP N/A
  • Fundamental
  • Price
  • PASW $0.75
  • COCP $1.15
  • Analyst Decision
  • PASW
  • COCP Strong Buy
  • Analyst Count
  • PASW 0
  • COCP 1
  • Target Price
  • PASW N/A
  • COCP $6.00
  • AVG Volume (30 Days)
  • PASW 394.3K
  • COCP 221.8K
  • Earning Date
  • PASW 11-15-2025
  • COCP 11-12-2025
  • Dividend Yield
  • PASW N/A
  • COCP N/A
  • EPS Growth
  • PASW N/A
  • COCP N/A
  • EPS
  • PASW N/A
  • COCP N/A
  • Revenue
  • PASW $8,286,193.00
  • COCP N/A
  • Revenue This Year
  • PASW N/A
  • COCP N/A
  • Revenue Next Year
  • PASW N/A
  • COCP N/A
  • P/E Ratio
  • PASW N/A
  • COCP N/A
  • Revenue Growth
  • PASW N/A
  • COCP N/A
  • 52 Week Low
  • PASW $0.69
  • COCP $1.01
  • 52 Week High
  • PASW $5.40
  • COCP $3.26
  • Technical
  • Relative Strength Index (RSI)
  • PASW N/A
  • COCP 46.02
  • Support Level
  • PASW N/A
  • COCP $1.01
  • Resistance Level
  • PASW N/A
  • COCP $1.30
  • Average True Range (ATR)
  • PASW 0.00
  • COCP 0.08
  • MACD
  • PASW 0.00
  • COCP 0.02
  • Stochastic Oscillator
  • PASW 0.00
  • COCP 48.78

About PASW Ping An Biomedical Co. Ltd. Ordinary Shares

Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: